Steward Partners Investment Advisory’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.94K | Hold |
178
| – | – | ﹤0.01% | 3980 |
|
|
2026
Q1 | $3.84K | Hold |
178
| – | – | ﹤0.01% | 3876 |
|
|
2025
Q4 | $2.44K | Hold |
178
| – | – | ﹤0.01% | 3910 |
|
|
2025
Q3 | $3.15K | Hold |
178
| – | – | ﹤0.01% | 3789 |
|
|
2025
Q2 | $2.69K | Sell |
178
-260
| -59% | -$4.31K | ﹤0.01% | 3668 |
|
|
2025
Q1 | $7.05K | Hold |
438
| – | – | ﹤0.01% | 3257 |
|
|
2024
Q4 | $7.63K | Hold |
438
| – | – | ﹤0.01% | 3213 |
|
|
2024
Q3 | $7.68K | Hold |
438
| – | – | ﹤0.01% | 3050 |
|
|
2024
Q2 | $4.9K | Buy |
438
+260
| +146% | +$2.45K | ﹤0.01% | 3054 |
|
|
2024
Q1 | $1.55K | Hold |
178
| – | – | ﹤0.01% | 3327 |
|
|
2023
Q4 | $2.18K | Hold |
178
| – | – | ﹤0.01% | 3186 |
|
|
2023
Q3 | $717 | Hold |
178
| – | – | ﹤0.01% | 3222 |
|
|
2023
Q2 | $1.28K | Hold |
178
| – | – | ﹤0.01% | 3098 |
|
|
2023
Q1 | $598 | Hold |
178
| – | – | ﹤0.01% | 3161 |
|
|
2022
Q4 | $493 | Hold |
178
| – | – | ﹤0.01% | 3197 |
|
|
2022
Q3 | $0 | Hold |
178
| – | – | ﹤0.01% | 3344 |
|
|
2022
Q2 | $0 | Hold |
178
| – | – | ﹤0.01% | 3337 |
|
|
2022
Q1 | $1K | Sell |
178
-1,050
| -86% | -$8.59K | ﹤0.01% | 3211 |
|
|
2021
Q4 | $18K | Sell |
1,228
-1,647
| -57% | -$32.8K | ﹤0.01% | 2371 |
|
|
2021
Q3 | $62K | Buy |
2,875
+2,125
| +283% | +$45.7K | ﹤0.01% | 1778 |
|
|
2021
Q2 | $12K | Hold |
750
| – | – | ﹤0.01% | 5728 |
|
|
2021
Q1 | $17.8K | Hold |
750
| – | – | ﹤0.01% | 2531 |
|
|
2020
Q4 | $18K | Hold |
750
| – | – | ﹤0.01% | 2100 |
|
|
2020
Q3 | $9K | Buy |
750
+50
| +7% | +$538 | ﹤0.01% | 2183 |
|
|
2020
Q2 | $7K | Hold |
700
| – | – | ﹤0.01% | 2173 |
|
|
2020
Q1 | $5K | Sell |
700
-1,500
| -68% | -$15.6K | ﹤0.01% | 2088 |
|
|
2019
Q4 | $29K | Sell |
2,200
-2,000
| -48% | -$28.5K | ﹤0.01% | 1641 |
|
|
2019
Q3 | $64K | Hold |
4,200
| – | – | ﹤0.01% | 1260 |
|
|
2019
Q2 | $55K | Buy |
+4,200
| New | +$57.3K | ﹤0.01% | 1302 |
|
|
2018
Q4 | – | Sell |
-2,665
| Closed | -$38K | – | 1767 |
|
|
2018
Q3 | $38K | Sell |
2,665
-1,000
| -27% | -$14.2K | ﹤0.01% | 1305 |
|
|
2018
Q2 | $55K | Hold |
3,665
| – | – | ﹤0.01% | 1069 |
|
|
2018
Q1 | $49K | Buy |
3,665
+1,000
| +38% | +$19K | ﹤0.01% | 1012 |
|
|
2017
Q4 | $62K | Hold |
2,665
| – | – | ﹤0.01% | 763 |
|
|
2017
Q3 | $49K | Sell |
2,665
-1,015
| -28% | -$23.1K | 0.01% | 699 |
|
|
2017
Q2 | $127K | Buy |
+3,680
| New | +$101K | 0.01% | 464 |
|
Other funds holding PLSE
PCM
Steward Partners Investment Advisory's PLSE Position: Q2 2026 in Review
Steward Partners Investment Advisory held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 178 shares worth $4.94K. The position accounts for ﹤0.01% of the portfolio, ranked #3980.
Steward Partners Investment Advisory first reported a position in PLSE in Q2 2017 and has held it in 35 quarters since. The position peaked at $127K in Q2 2017. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.
- Steward Partners Investment Advisory held 178 shares of Pulse Biosciences worth $4.94K as of Q2 2026.
- Steward Partners Investment Advisory left its Pulse Biosciences share count unchanged in Q2 2026.
- Pulse Biosciences made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3980 holding.
- Steward Partners Investment Advisory first reported a position in Pulse Biosciences in Q2 2017 and has held it in 35 quarters since.
- Steward Partners Investment Advisory's Pulse Biosciences position peaked at $127K in Q2 2017.
- 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.